Forsta AP Fonden Buys 31,000 Shares of Procter & Gamble Company (The) $PG

Forsta AP Fonden lifted its position in Procter & Gamble Company (The) (NYSE:PGFree Report) by 5.1% in the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 635,900 shares of the company’s stock after purchasing an additional 31,000 shares during the period. Procter & Gamble accounts for about 0.7% of Forsta AP Fonden’s investment portfolio, making the stock its 19th biggest position. Forsta AP Fonden’s holdings in Procter & Gamble were worth $101,312,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the company. Kingstone Capital Partners Texas LLC raised its holdings in shares of Procter & Gamble by 655,209.0% in the second quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock valued at $11,832,680,000 after acquiring an additional 76,017,350 shares in the last quarter. Northern Trust Corp increased its position in Procter & Gamble by 0.8% during the 1st quarter. Northern Trust Corp now owns 29,644,000 shares of the company’s stock valued at $5,051,930,000 after purchasing an additional 248,792 shares during the period. Price T Rowe Associates Inc. MD raised its holdings in shares of Procter & Gamble by 13.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock valued at $3,660,737,000 after purchasing an additional 2,466,308 shares in the last quarter. Goldman Sachs Group Inc. lifted its position in shares of Procter & Gamble by 3.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 17,405,539 shares of the company’s stock worth $2,966,252,000 after purchasing an additional 583,629 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in shares of Procter & Gamble by 6.3% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 17,293,428 shares of the company’s stock valued at $2,947,146,000 after purchasing an additional 1,018,865 shares in the last quarter. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

PG has been the subject of a number of recent research reports. Bank of America reduced their price objective on shares of Procter & Gamble from $180.00 to $174.00 and set a “buy” rating for the company in a research note on Wednesday, October 8th. JPMorgan Chase & Co. boosted their price target on Procter & Gamble from $163.00 to $165.00 and gave the stock a “neutral” rating in a research report on Monday, October 27th. Dbs Bank raised Procter & Gamble to a “moderate buy” rating in a research report on Tuesday, October 28th. Barclays cut their target price on Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating on the stock in a research note on Wednesday, October 1st. Finally, Berenberg Bank increased their price target on shares of Procter & Gamble from $152.00 to $154.00 and gave the company a “hold” rating in a research report on Wednesday, September 17th. Twelve analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $171.53.

Check Out Our Latest Stock Analysis on PG

Procter & Gamble Price Performance

NYSE PG opened at $148.54 on Wednesday. The company has a market cap of $347.09 billion, a price-to-earnings ratio of 21.68, a PEG ratio of 3.87 and a beta of 0.36. The company has a debt-to-equity ratio of 0.46, a current ratio of 0.71 and a quick ratio of 0.51. The stock’s fifty day moving average price is $152.51 and its 200 day moving average price is $156.83. Procter & Gamble Company has a 1 year low of $144.09 and a 1 year high of $180.43.

Procter & Gamble (NYSE:PGGet Free Report) last issued its quarterly earnings results on Friday, October 24th. The company reported $1.99 EPS for the quarter, topping analysts’ consensus estimates of $1.90 by $0.09. The company had revenue of $22.39 billion during the quarter, compared to analysts’ expectations of $22.23 billion. Procter & Gamble had a return on equity of 32.63% and a net margin of 19.74%.The firm’s revenue was up 3.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.93 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. As a group, equities research analysts forecast that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, November 17th. Investors of record on Friday, October 24th will be issued a $1.0568 dividend. This represents a $4.23 annualized dividend and a yield of 2.8%. The ex-dividend date is Friday, October 24th. Procter & Gamble’s dividend payout ratio is 61.61%.

Insider Activity at Procter & Gamble

In other Procter & Gamble news, CEO Jon R. Moeller sold 40,119 shares of Procter & Gamble stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $6,309,515.13. Following the completion of the sale, the chief executive officer directly owned 319,375 shares in the company, valued at approximately $50,228,106.25. The trade was a 11.16% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, COO Shailesh Jejurikar sold 13,039 shares of the stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $2,050,643.53. Following the completion of the sale, the chief operating officer owned 28,036 shares in the company, valued at $4,409,221.72. The trade was a 31.74% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 150,488 shares of company stock worth $23,529,718 in the last ninety days. 0.20% of the stock is owned by company insiders.

About Procter & Gamble

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Featured Articles

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.